Aldawaa Medical Services Co. (DMSCO) reported a net profit of SAR 95.3 million for Q1 2024, leaping 25% from SAR 76.3 million in the same period last year.
Item | Q1 2023 | Q1 2024 | Change |
---|---|---|---|
Revenues | 1,407.59 | 1,516.42 | 7.7 % |
Gross Income | 534.98 | 564.42 | 5.5 % |
Operating Income | 116.00 | 130.49 | 12.5 % |
Net Income | 76.25 | 95.33 | 25.0 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 0.90 | 1.12 | 25.0 % |
Item | Q4 2023 | Q1 2024 | Change |
---|---|---|---|
Revenues | 1,458.09 | 1,516.42 | 4.0 % |
Gross Income | 525.09 | 564.42 | 7.5 % |
Operating Income | 140.39 | 130.49 | (7.1 %) |
Net Income | 92.35 | 95.33 | 3.2 % |
Average Shares | 85.00 | 85.00 | - |
EPS (Riyals) | 1.09 | 1.12 | 3.2 % |
Revenues in the first quarter of 2024 grew 7.7% year-on-year (YoY) to SAR 108.8 million, due to the increase in sales activities across all channels.
Gross profit increased by 5.5% YoY to SAR 29.4 million, and operating profit grew by 13.6% YoY on controlling expenses.
Sequentially, Q1 2024 net profit was up 3.2% from SAR 92.35 million in Q4 2023, mainly fueled by a 4% rise quarter-on-quarter in revenues to SAR 58.3 million.
Total shareholders’ equity, no minority interest, rose to SAR 1.29 billion as of March 31, 2024, from SAR 1.07 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}